Cargando…

苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800227/
https://www.ncbi.nlm.nih.gov/pubmed/35968596
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.06.012
_version_ 1784861248946438144
collection PubMed
description
format Online
Article
Text
id pubmed-9800227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-98002272022-12-30 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2022-06 /pmc/articles/PMC9800227/ /pubmed/35968596 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.06.012 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 短篇论著
苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析
title 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析
title_full 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析
title_fullStr 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析
title_full_unstemmed 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析
title_short 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析
title_sort 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800227/
https://www.ncbi.nlm.nih.gov/pubmed/35968596
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.06.012
work_keys_str_mv AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī
AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī
AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī
AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī
AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī
AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī
AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī
AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī